Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 26, 2026 16:03 ET | Source: NurExone Biologic Inc

NurExone Strengthens U.S. Manufacturing Strategy Through Exo-Top Sublicense Agreement

TORONTO and HAIFA, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biotechnology company developing...
March 26, 2026 09:00 ET | Source: Gordon Brothers

Gordon Brothers Expands Broyhill with Three New Licensees

Boston, March 26, 2026 (GLOBE NEWSWIRE) -- Gordon Brothers, the global asset experts, announced the expansion of Broyhill with three new licensees—Living Style, Bedding Industries of America and...
March 25, 2026 08:30 ET | Source: Brazilian Rare Earths

BRE Secures Monte Alto Trial Mining Licence

BRE Secures Monte Alto Trial Mining Licence
March 24, 2026 08:31 ET | Source: 20/20 Biolabs Inc.

20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program

20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare
March 24, 2026 06:00 ET | Source: Yatiri Bio

Yatiri Bio Enters Exclusive Option to In-License Agreement with Oscotec for Denfivontinib in AML

Yatiri Bio is a precision medicine company focused on identifying and validating biomarkers that predict therapeutic response in oncology.
March 18, 2026 09:00 ET | Source: KALA BIO, Inc.

Red Light Holland Engages Kala Bio’s Researgency.AI Platform to Support Clinical Development of Filament’s Patented PEX010 Botanical Psilocybin Drug Candidate

AI-powered autonomous research agents to be deployed in support of PEX010 clinical development strategy, leveraging Kala Bio’s purpose-built agentic AI platform for the biotechnology industry TORONTO...
March 18, 2026 08:00 ET | Source: VIRAL VECTOR MANUFACTURING FACILITY PTY. LTD.

Viral Vector Manufacturing (VVMF) enters into licensing agreement with OXB, gaining access to the OXB AAV and LV viral vector platforms

Australia's only viral vector CDMO, Viral Vector Manufacturing Facility Pty Ltd (VVMF), enters into a licensing and option agreement with OXB (LSE:OXB).
March 17, 2026 08:30 ET | Source: PolyPid Ltd.

PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀’s New Drug Application

FDA Grants $4.3 Million Small Business Waiver, Enabling Focus on Commercialization Preparations Company On Track to Initiate NDA Submission by the End of this Month PETACH TIKVA, Israel, March 17,...
March 17, 2026 08:00 ET | Source: 1606 CORP.

1606 Corp. Signs Agreement to Acquire Data-Center-Ready Property with Captive Power on 132 Acres

1606 Corp. Signs Agreement to Acquire Data-Center-Ready Property with Captive Power on 132 Acres
March 16, 2026 07:30 ET | Source: Zevra Therapeutics

Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million

BOSTON, March 16, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare...